当前位置: X-MOL 学术Liver Int. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Hepatocellular carcinoma risk in hepatitis C stage-3 fibrosis after sustained virological response with direct-acting antivirals
Liver International ( IF 6.0 ) Pub Date : 2021-08-15 , DOI: 10.1111/liv.15032
María Sánchez-Azofra 1 , Inmaculada Fernández 2 , María L García-Buey 3 , Lourdes Domínguez-Domínguez 4, 5 , Conrado M Fernández-Rodríguez 6 , Antonio Mancebo 7 , Lucía Bonet 8 , Pablo Ryan 9 , Francisco Gea 10 , Antonio Díaz-Sánchez 11 , Marian García-Mayor 12 , Luz Martín-Carbonero 13 , Pilar Castillo 1 , María L Manzano 2 , Leticia González-Moreno 3 , Federico Pulido 4, 5 , María L Gutiérrez 6 , José M Moreno 7 , Irene M García-Amengual 8 , Guillermo Cuevas 9 , Antonio Guerrero 10 , Miguel Rivero-Fernández 11 , María E Portales 12 , María L Montes 13 , Antonio Olveira 1
Affiliation  

Patients with chronic hepatitis C and stage 3 fibrosis are thought to remain at risk of hepatocellular carcinoma after sustained virological response. We investigated this risk in a large cohort of patients with well-defined stage 3 fibrosis.

中文翻译:

直接作用抗病毒药物持续病毒学应答后丙型肝炎 3 期纤维化的肝细胞癌风险

慢性丙型肝炎和 3 期纤维化患者被认为在持续的病毒学应答后仍有患肝细胞癌的风险。我们在一大群明确定义的 3 期纤维化患者中调查了这种风险。
更新日期:2021-08-15
down
wechat
bug